Aarti Pharmalabs
AARTIPHARM · Pharma > Pharmaceuticals & Drugs Listing date: Jan. 30, 2023

Stock Price vs Company Growth
1d
1.3%
1w
1.0%
1m
3.3%
3m
22.3%
6m
11.0%
1y
78.1%
all
38.0%
Created with Highcharts 8.2.2SalesProfitPriceDividendQtr SalesOperating CashflowJun22Dec22Jun23Dec23Jun24Latest

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

740 1.3%
548
837
Company Overview

Sales
2,057 Cr
Growth: 5.2%
Profit after Tax
249 Cr
Growth: 9.3%
Small Cap
6,705 Cr
P/E: 26.9x
Industry P/E: 29.7x
Created with Highcharts 8.2.2HistoricalGrowthValuationAttractivenessProfitabilityIndustryOutlookPriceStability10
Fundamentals

Sales (Cr) ₹ 2,057
Growth 5.2%
EBITDA 21.2%
P/S 3.3x
Dividend 0.4%
P/E 26.9x
Book Value ₹ 214
PEG Ratio 5.1x
ROE 13.5%
P/B 3.4x
Shareholding Pattern

Increase    Decrease    No change
Company Profile Detailed

The company is an, internationally recognised manufacturer of Active Pharmaceutical Ingredients (API), pharmaceutical intermediates, New Chemical Entities (NCE), and xanthine derivatives situated in India. In order to build a sustainable future, it integrates process chemistry proficiency (recipe focus) with scale-up engineering proficiency (asset utilisation).
Investors (9)
Followers (1)